169 related articles for article (PubMed ID: 19355850)
21. Regulatable transgenic mouse models of Alzheimer disease: onset, reversibility and spreading of Tau pathology.
Hochgräfe K; Sydow A; Mandelkow EM
FEBS J; 2013 Sep; 280(18):4371-81. PubMed ID: 23517246
[TBL] [Abstract][Full Text] [Related]
22. Characterization of a Mouse Model of Alzheimer's Disease Expressing Aβ4-42 and Human Mutant Tau.
Zampar S; Wirths O
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069029
[TBL] [Abstract][Full Text] [Related]
23. NMDA receptor dysfunction contributes to impaired brain-derived neurotrophic factor-induced facilitation of hippocampal synaptic transmission in a Tau transgenic model.
Burnouf S; Martire A; Derisbourg M; Laurent C; Belarbi K; Leboucher A; Fernandez-Gomez FJ; Troquier L; Eddarkaoui S; Grosjean ME; Demeyer D; Muhr-Tailleux A; Buisson A; Sergeant N; Hamdane M; Humez S; Popoli P; Buée L; Blum D
Aging Cell; 2013 Feb; 12(1):11-23. PubMed ID: 23082852
[TBL] [Abstract][Full Text] [Related]
24. Tau-amyloid interactions in the rTgTauEC model of early Alzheimer's disease suggest amyloid-induced disruption of axonal projections and exacerbated axonal pathology.
Pooler AM; Polydoro M; Wegmann SK; Pitstick R; Kay KR; Sanchez L; Carlson GA; Gomez-Isla T; Albers MW; Spires-Jones TL; Hyman BT
J Comp Neurol; 2013 Dec; 521(18):4236-48. PubMed ID: 23839581
[TBL] [Abstract][Full Text] [Related]
25. Alzheimer's associated amyloid and tau deposition co-localizes with a homeostatic myelin repair pathway in two mouse models of post-stroke mixed dementia.
Nguyen TV; Hayes M; Zbesko JC; Frye JB; Congrove NR; Belichenko NP; McKay BS; Longo FM; Doyle KP
Acta Neuropathol Commun; 2018 Sep; 6(1):100. PubMed ID: 30249297
[TBL] [Abstract][Full Text] [Related]
26. Amyloid and tau neuropathology differentially affect prefrontal synaptic plasticity and cognitive performance in mouse models of Alzheimer's disease.
Lo AC; Iscru E; Blum D; Tesseur I; Callaerts-Vegh Z; Buée L; De Strooper B; Balschun D; D'Hooge R
J Alzheimers Dis; 2013; 37(1):109-25. PubMed ID: 23788007
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis B core VLP-based mis-disordered tau vaccine elicits strong immune response and alleviates cognitive deficits and neuropathology progression in Tau.P301S mouse model of Alzheimer's disease and frontotemporal dementia.
Ji M; Xie XX; Liu DQ; Yu XL; Zhang Y; Zhang LX; Wang SW; Huang YR; Liu RT
Alzheimers Res Ther; 2018 Jun; 10(1):55. PubMed ID: 29914543
[TBL] [Abstract][Full Text] [Related]
28. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.
Chaney AM; Lopez-Picon FR; Serrière S; Wang R; Bochicchio D; Webb SD; Vandesquille M; Harte MK; Georgiadou C; Lawrence C; Busson J; Vercouillie J; Tauber C; Buron F; Routier S; Reekie T; Snellman A; Kassiou M; Rokka J; Davies KE; Rinne JO; Salih DA; Edwards FA; Orton LD; Williams SR; Chalon S; Boutin H
Theranostics; 2021; 11(14):6644-6667. PubMed ID: 34093845
[TBL] [Abstract][Full Text] [Related]
29. Neurophysiological effects of human-derived pathological tau conformers in the APPKM670/671NL.PS1/L166P amyloid mouse model of Alzheimer's disease.
Tok S; Maurin H; Delay C; Crauwels D; Manyakov NV; Van Der Elst W; Moechars D; Drinkenburg WHIM
Sci Rep; 2022 May; 12(1):7784. PubMed ID: 35546164
[TBL] [Abstract][Full Text] [Related]
30. Voluntary Running Attenuates Memory Loss, Decreases Neuropathological Changes and Induces Neurogenesis in a Mouse Model of Alzheimer's Disease.
Tapia-Rojas C; Aranguiz F; Varela-Nallar L; Inestrosa NC
Brain Pathol; 2016 Jan; 26(1):62-74. PubMed ID: 25763997
[TBL] [Abstract][Full Text] [Related]
31. Cholinergic Basal Forebrain Lesion Decreases Neurotrophin Signaling without Affecting Tau Hyperphosphorylation in Genetically Susceptible Mice.
Turnbull MT; Coulson EJ
J Alzheimers Dis; 2017; 55(3):1141-1154. PubMed ID: 27767994
[TBL] [Abstract][Full Text] [Related]
32. Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models.
Götz J; Schild A; Hoerndli F; Pennanen L
Int J Dev Neurosci; 2004 Nov; 22(7):453-65. PubMed ID: 15465275
[TBL] [Abstract][Full Text] [Related]
33. Brain insulin response and peripheral metabolic changes in a Tau transgenic mouse model.
Leboucher A; Ahmed T; Caron E; Tailleux A; Raison S; Joly-Amado A; Marciniak E; Carvalho K; Hamdane M; Bantubungi K; Lancel S; Eddarkaoui S; Caillierez R; Vallez E; Staels B; Vieau D; Balschun D; Buee L; Blum D
Neurobiol Dis; 2019 May; 125():14-22. PubMed ID: 30665005
[TBL] [Abstract][Full Text] [Related]
34. High-Molecular-Weight Paired Helical Filaments from Alzheimer Brain Induces Seeding of Wild-Type Mouse Tau into an Argyrophilic 4R Tau Pathology in Vivo.
Audouard E; Houben S; Masaracchia C; Yilmaz Z; Suain V; Authelet M; De Decker R; Buée L; Boom A; Leroy K; Ando K; Brion JP
Am J Pathol; 2016 Oct; 186(10):2709-22. PubMed ID: 27497324
[TBL] [Abstract][Full Text] [Related]
35. Amyloid precursor protein reduction enhances the formation of neurofibrillary tangles in a mutant tau transgenic mouse model.
Vanden Dries V; Stygelbout V; Pierrot N; Yilmaz Z; Suain V; De Decker R; Buée L; Octave JN; Brion JP; Leroy K
Neurobiol Aging; 2017 Jul; 55():202-212. PubMed ID: 28464981
[TBL] [Abstract][Full Text] [Related]
36. Immunolesion-induced loss of cholinergic projection neurones promotes β-amyloidosis and tau hyperphosphorylation in the hippocampus of triple-transgenic mice.
Härtig W; Saul A; Kacza J; Grosche J; Goldhammer S; Michalski D; Wirths O
Neuropathol Appl Neurobiol; 2014 Feb; 40(2):106-20. PubMed ID: 23566195
[TBL] [Abstract][Full Text] [Related]
37. Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease.
Yang JT; Wang ZJ; Cai HY; Yuan L; Hu MM; Wu MN; Qi JS
Neurosci Bull; 2018 Oct; 34(5):736-746. PubMed ID: 30099679
[TBL] [Abstract][Full Text] [Related]
38. Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice.
Chalermpalanupap T; Schroeder JP; Rorabaugh JM; Liles LC; Lah JJ; Levey AI; Weinshenker D
J Neurosci; 2018 Jan; 38(1):74-92. PubMed ID: 29133432
[TBL] [Abstract][Full Text] [Related]
39. Topographical Visualization of the Reciprocal Projection between the Medial Septum and the Hippocampus in the 5XFAD Mouse Model of Alzheimer's Disease.
Kim S; Nam Y; Jeong YO; Park HH; Lee SK; Shin SJ; Jung H; Kim BH; Hong SB; Park YH; Kim J; Yu J; Yoo DH; Park SH; Jeon SG; Moon M
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31426329
[TBL] [Abstract][Full Text] [Related]
40. Different pathways of molecular pathophysiology underlie cognitive and motor tauopathy phenotypes in transgenic models for Alzheimer's disease and frontotemporal lobar degeneration.
Melis V; Zabke C; Stamer K; Magbagbeolu M; Schwab K; Marschall P; Veh RW; Bachmann S; Deiana S; Moreau PH; Davidson K; Harrington KA; Rickard JE; Horsley D; Garman R; Mazurkiewicz M; Niewiadomska G; Wischik CM; Harrington CR; Riedel G; Theuring F
Cell Mol Life Sci; 2015 Jun; 72(11):2199-222. PubMed ID: 25523019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]